Table of Contents Author Guidelines Submit a Manuscript
Autism Research and Treatment
Volume 2012, Article ID 205362, 4 pages
http://dx.doi.org/10.1155/2012/205362
Research Article

Decreased Levels of EGF in Plasma of Children with Autism Spectrum Disorder

1Department of Medical Microbiology and Immunology, University of California, Davis, USA
2The M.I.N.D. Institute, University of California, Davis, Sacramento, CA 95817, USA
3Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, USA

Received 14 September 2011; Revised 3 November 2011; Accepted 16 December 2011

Academic Editor: Antonio M. Persico

Copyright © 2012 Charity Onore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. APA, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Inc., Arlington, Va, USA, 2000.
  2. C. Rice, “Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, United States, 2006,” Morbidity and Mortality Weekly Report, vol. 58, no. 10, pp. 1–20, 2009. View at Google Scholar · View at Scopus
  3. T. Nickl-Jockschat and T. M. Michel, “The role of neurotrophic factors in autism,” Molecular Psychiatry, vol. 16, pp. 478–490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Heck, D. L. Laskin, C. R. Gardner, and J. D. Laskin, “Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing,” Journal of Biological Chemistry, vol. 267, no. 30, pp. 21277–21280, 1992. View at Google Scholar · View at Scopus
  5. K. Okunishi, M. Dohi, K. Nakagome et al., “A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function,” Journal of Immunology, vol. 175, no. 7, pp. 4745–4753, 2005. View at Google Scholar · View at Scopus
  6. J. A. Vega, O. García-Suárez, J. Hannestad, M. Pérez-Pérez, and A. Germanà, “Neurotrophins and the immune system,” Journal of Anatomy, vol. 203, no. 1, pp. 1–19, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Tabakman, S. Lecht, S. Sephanova, H. Arien-Zakay, and P. Lazarovici, “Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury,” Progress in Brain Research, vol. 146, pp. 387–401, 2004. View at Google Scholar · View at Scopus
  8. D. L. Vargas, C. Nascimbene, C. Krishnan, A. W. Zimmerman, and C. A. Pardo, “Neuroglial activation and neuroinflammation in the brain of patients with autism,” Annals of Neurology, vol. 57, no. 1, pp. 67–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Li, A. Chauhan, A. M. Sheikh et al., “Elevated immune response in the brain of autistic patients,” Journal of Neuroimmunology, vol. 207, no. 1-2, pp. 111–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Ashwood, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, I. N. Pessah, and J. Van de Water, “Altered T cell responses in children with autism,” Brain, Behavior, and Immunity, vol. 25, no. 5, pp. 840–849, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Enstrom, C. E. Onore, J. A. Van de Water, and P. Ashwood, “Differential monocyte responses to TLR ligands in children with autism spectrum disorders,” Brain, Behavior, and Immunity, vol. 24, no. 1, pp. 64–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Ashwood, P. Krakowiak, I. Hertz-Picciotto, R. Hansen, I. Pessah, and J. Van de Water, “Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome,” Brain, Behavior, and Immunity, vol. 25, no. 1, pp. 40–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Xian and X. F. Zhou, “Roles of transforming growth factor-α and related molecules in the nervous system,” Molecular Neurobiology, vol. 20, no. 2-3, pp. 157–183, 1999. View at Google Scholar · View at Scopus
  14. C. J. Xian and X. F. Zhou, “EGF family of growth factors: essential roles and functional redundancy in the nerve system,” Frontiers in Bioscience, vol. 9, pp. 85–92, 2004. View at Google Scholar · View at Scopus
  15. S. Pastore and F. Mascia, “Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin,” Expert Review of Dermatology, vol. 3, no. 5, pp. 525–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Miettinen, J. E. Berger, J. Meneses et al., “Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor,” Nature, vol. 376, no. 6538, pp. 337–341, 1995. View at Google Scholar · View at Scopus
  17. T. Toyoda, K. Nakamura, K. Yamada et al., “SNP analyses of growth factor genes EGF, TGFβ-1, and HGF reveal haplotypic association of EGF with autism,” Biochemical and Biophysical Research Communications, vol. 360, no. 4, pp. 715–720, 2007. View at Publisher · View at Google Scholar
  18. K. Suzuki, K. Hashimoto, Y. Iwata et al., “Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism,” Biological Psychiatry, vol. 62, no. 3, pp. 267–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Levitt, K. L. Eagleson, and E. M. Powell, “Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders,” Trends in Neurosciences, vol. 27, no. 7, pp. 400–406, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Sugihara, K. Hashimoto, Y. Iwata et al., “Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 2, pp. 412–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. B. Campbell, R. D'Oronzio, K. Garbett et al., “Disruption of cerebral cortex MET signaling in autism spectrum disorder,” Annals of Neurology, vol. 62, no. 3, pp. 243–250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Singer, ““Phenome” project set to pin down subgroups of autism,” Nature Medicine, vol. 11, no. 6, p. 583, 2005. View at Google Scholar · View at Scopus
  23. C. Lord, M. Rutter, S. Goode et al., “Autism diagnostic observation schedule: a standardized observation of communicative and social behavior,” Journal of Autism and Developmental Disorders, vol. 19, no. 2, pp. 185–212, 1989. View at Google Scholar · View at Scopus
  24. C. Lord, M. Rutter, and A. L. Couteur, “Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders,” Journal of Autism and Developmental Disorders, vol. 24, no. 5, pp. 659–685, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Berument, M. Rutter, C. Lord, A. Pickles, and A. Bailey, “Autism screening questionnaire: diagnostic validity,” British Journal of Psychiatry, vol. 175, pp. 444–451, 1999. View at Google Scholar · View at Scopus
  26. M. Careaga, J. Van de Water, and P. Ashwood, “Immune dysfunction in autism: a pathway to treatment,” Neurotherapeutics, vol. 7, no. 3, pp. 283–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. G. Craig, V. Tropepe, C. M. Morshead, B. A. Reynolds, S. Weiss, and D. Van Der Kooy, “In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain,” Journal of Neuroscience, vol. 16, no. 8, pp. 2649–2658, 1996. View at Google Scholar · View at Scopus
  28. W. Pan and A. J. Kastin, “Entry of EGF into brain is rapid and saturable,” Peptides, vol. 20, no. 9, pp. 1091–1098, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Farrell, “Epidermal growth factor for ulcerative colitis,” New England Journal of Medicine, vol. 349, no. 4, pp. 395–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sinha, J. Nightingale, K. P. West, J. Berlanga-Acosta, and R. J. Playford, “Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis,” New England Journal of Medicine, vol. 349, no. 4, pp. 350–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Horvath and J. A. Perman, “Autism and gastrointestinal symptoms,” Current Gastroenterology Reports, vol. 4, no. 3, pp. 251–258, 2002. View at Google Scholar · View at Scopus
  32. P. Ashwood, A. Anthony, A. A. Pellicer, F. Torrente, J. A. Walker-Smith, and A. J. Wakefield, “Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology,” Journal of Clinical Immunology, vol. 23, no. 6, pp. 504–517, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Ashwood, A. Anthony, F. Torrente, and A. J. Wakefield, “Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10,” Journal of Clinical Immunology, vol. 24, no. 6, pp. 664–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Ashwood and A. J. Wakefield, “Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms,” Journal of Neuroimmunology, vol. 173, no. 1-2, pp. 126–134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Ramirez, D. Hsu, A. Patel et al., “Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma,” Clinical Endocrinology, vol. 53, no. 5, pp. 635–644, 2000. View at Publisher · View at Google Scholar · View at Scopus